Literature DB >> 16693360

Retrolental Fibroplasia in the Premature Infant: V. Further Studies on Fibroplastic Overgrowth of the Persistent Tunica Vasculosa Lentis.

T L Terry.   

Abstract

Entities:  

Year:  1944        PMID： 16693360      PMCID： PMC1315141     

Source DB:  PubMed          Journal:  Trans Am Ophthalmol Soc        ISSN： 0065-9533


× No keyword cloud information.
  13 in total

Review 1.  Laser treatment for retinopathy of prematurity.

Authors:  Samuel K Houston; Charles C Wykoff; Audina M Berrocal; Ditte J Hess; Timothy G Murray
Journal:  Lasers Med Sci       Date:  2011-12-02       Impact factor: 3.161

2.  Quantifying three-dimensional rodent retina vascular development using optical tissue clearing and light-sheet microscopy.

Authors:  Jasmine N Singh; Taylor M Nowlin; Gregory J Seedorf; Steven H Abman; Douglas P Shepherd
Journal:  J Biomed Opt       Date:  2017-07-01       Impact factor: 3.170

Review 3.  Anti-Vascular Endothelial Growth Factor and the Evolving Management Paradigm for Retinopathy of Prematurity.

Authors:  Dana Darwish; Ru-Ik Chee; Samir N Patel; Karyn Jonas; Susan Ostmo; J Peter Campbell; Michael F Chiang; R V Paul Chan
Journal:  Asia Pac J Ophthalmol (Phila)       Date:  2018-05-29

4.  The role of oxygen in retrolental fibroplasia.

Authors:  A Patz
Journal:  Trans Am Ophthalmol Soc       Date:  1968

5.  Lutein facilitates physiological revascularization in a mouse model of retinopathy of prematurity.

Authors:  Zhongjie Fu; Steven S Meng; Samuel B Burnim; Lois Eh Smith; Amy Cy Lo
Journal:  Clin Exp Ophthalmol       Date:  2017-01-29       Impact factor: 4.207

6.  Optimal oxygen saturation in premature infants.

Authors:  Meayoung Chang
Journal:  Korean J Pediatr       Date:  2011-09-30

Review 7.  Current update on retinopathy of prematurity: screening and treatment.

Authors:  Jing Chen; Andreas Stahl; Ann Hellstrom; Lois E Smith
Journal:  Curr Opin Pediatr       Date:  2011-04       Impact factor: 2.856

Review 8.  Emerging treatments for retinopathy of prematurity.

Authors:  Iason S Mantagos; Deborah K Vanderveen; Lois E H Smith
Journal:  Semin Ophthalmol       Date:  2009 Mar-Apr       Impact factor: 1.975

9.  Intravitreal bevacizumab injection in aggressive posterior retinopathy of prematurity compared with type I retinopathy of prematurity.

Authors:  Amir Eftekhari Milani; Narges Hassanpoor; Mohammadreza Mousavi Mirkala; Arash Taheri; Ali Golizade; Mohamad Reza Niyousha
Journal:  Int Ophthalmol       Date:  2019-11-11       Impact factor: 2.031

10.  Early experience with intravitreal bevacizumab combined with laser treatment for retinopathy of prematurity.

Authors:  Ayesha E Ahmed; Roomasa Channa; Jibran Durrani; Azam Ali; Khabir Ahmad
Journal:  Middle East Afr J Ophthalmol       Date:  2010-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.